Please login to the form below

Not currently logged in
Email:
Password:

Stada

This page shows the latest Stada news and features for those working in and with pharma, biotech and healthcare.

Post-merger Celgene to lead pharma growth

Post-merger Celgene to lead pharma growth

Behind Celgene is a cohort of five companies which are expected to post profit growth of 6-10%: AbbVie, AstraZeneca, Eli Lilly, Stada and Takeda.

Latest news

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    German pharma company finally comes under new ownership. After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain ... The buyout - which is the largest for a

  • Time running out on new Stada takeover bid Time running out on new Stada takeover bid

    Only 34% of shareholders have backed the deal so far. With a deadline looming on Wednesday, only a third of shareholders in German pharma company Stada have accepted the takeover bid ... As of Friday around 34% of Stada's shareholders had accepted, well

  • Trouble at the top of Stada as Bain and Cinven mull fresh bid Trouble at the top of Stada as Bain and Cinven mull fresh bid

    The chief executive and finance chief of Stada have stepped down in the wake of the failed takeover by private equity firms Bain and Cinven, citing "personal reasons". ... Tjeenk Willink said his first priorities will be to "continue to implement Stada's

  • No deal for Stada as private equity takeover bid collapses No deal for Stada as private equity takeover bid collapses

    66 per share deal which would have valued Stada at around 5.3bn including debt. ... Stada's board had lent its support to the Bain-Cinven offer over a rival 58 per share bid from Advent and Permira.

  • Private equity firms agree deal to take over Stada Private equity firms agree deal to take over Stada

    Cinven and Bain Capital made what Stada said was the "most financially appealing offer" of 66 per share, topping an earlier bid from Advent International of 58. ... Analysts have suggested that Stada will form the foundation for a series of bolt-on

More from news
Approximately 9 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada for $5.63bn? ... So why did Bain/Cinven acquire Stada at a high price? Almost certainly it was because they were in

  • Deal Watch February 2017 Deal Watch February 2017

    What is more than rumour, is the interest from several parties in acquiring the German generic company, Stada, which has pan-European capabilities and a foothold in Russia. ... Whatever happens to Stada this represents another chapter in the evolution of

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    485. OptiMedica  /. Abbott. Acquisition. Ophthalmic device company. 400. Thornton &Ross /. Stada Arzneimittel. Acquisition. OTC manufacturer. 345. Endosense  /. St Jude Medical.

  • Pharma deals during August 2013 Pharma deals during August 2013

    Generics business consolidation was also evident on this side of the pond. In a defensive move the German drugmaker Stada Arzneimittel announced the $345m take-over of the UK OTC company, ... Thornton &Ross.Thornton &Ross is one of the fastest growing

  • Pharma deals during November 2012 Pharma deals during November 2012

    the subject of interest from companies such as GSK and Stada for some time. It is currently majority owned by Russia's largest drugstore chain “36.6” and has enjoyed 20

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Britannia promotes Robert Wood Britannia promotes Robert Wood

    Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics